These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21541208)

  • 21. Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.
    Lyu X; Guo Z; Li Y; Fan R; Song Y
    BMC Med Genet; 2018 Apr; 19(1):60. PubMed ID: 29649976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation.
    Vieth S; Ammann S; Schwarz K; Härtel C; Schultz C; Lehmberg K; Lauten M
    Klin Padiatr; 2013 Nov; 225(6):343-6. PubMed ID: 24166087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.
    Wu L; Yang F; Wang J; Yang F; Liang M; Yang H
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1873. PubMed ID: 35092357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
    Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
    Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key Promoter Sequence.
    Sbihi Z; Tanita K; Bachelet C; Bole C; Jabot-Hanin F; Tores F; Le Loch M; Khodr R; Hoshino A; Lenoir C; Oleastro M; Villa M; Spossito L; Prieto E; Danielian S; Brunet E; Picard C; Taga T; Abdrabou SSMA; Isoda T; Yamada M; Palma A; Kanegane H; Latour S
    J Clin Immunol; 2022 Apr; 42(3):559-571. PubMed ID: 35000057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XIAP deficiency syndrome in humans.
    Latour S; Aguilar C
    Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Flow Cytometric Screening of SAP and XIAP Expression Accurately Identifies Patients with SH2D1A and XIAP/BIRC4 Mutations.
    Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
    Cytometry B Clin Cytom; 2014 Feb; ():. PubMed ID: 26305518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
    Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
    Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.
    Marsh RA; Villanueva J; Kim MO; Zhang K; Marmer D; Risma KA; Jordan MB; Bleesing JJ; Filipovich AH
    Clin Immunol; 2009 Jul; 132(1):116-23. PubMed ID: 19398375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful allogeneic hematopoietic stem cell transplantation in a boy with X-linked inhibitor of apoptosis deficiency presenting with hemophagocytic lymphohistiocytosis: A case report.
    Jiang MY; Guo X; Sun SW; Li Q; Zhu YP
    Exp Ther Med; 2016 Sep; 12(3):1341-1344. PubMed ID: 27602064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked lymphoproliferative syndromes: brothers or distant cousins?
    Filipovich AH; Zhang K; Snow AL; Marsh RA
    Blood; 2010 Nov; 116(18):3398-408. PubMed ID: 20660790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.
    Yang X; Hoshino A; Taga T; Kunitsu T; Ikeda Y; Yasumi T; Yoshida K; Wada T; Miyake K; Kubota T; Okuno Y; Muramatsu H; Adachi Y; Miyano S; Ogawa S; Kojima S; Kanegane H
    J Clin Immunol; 2015 Apr; 35(3):244-8. PubMed ID: 25744037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
    Aguilar C; Latour S
    J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.